Clinicopathologic Analysis of HER-2/neu Immunoexpression among Various Histologic Subtypes and Grades of Osteosarcoma

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh, Charles L. Vogel, Debu Tripathy et al. · Journal of Clinical Oncology · 1999 · 2.8K citations

Medicine, Oncology, Pharmacology +17

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Mark D. Pegram, A. Lipton, Daniel F. Hayes et al. · Journal of Clinical Oncology · 1998 · 1.1K citations

Medicine, Oncology, Pharmacology +17

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

C Wright, Brian Angus, S Nicholson et al. · PubMed · 1989 · 587 citations

Medicine, Oncology, Pathology +17

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Michael F. Press, Giun‐Yi Hung, William Godolphin et al. · PubMed · 1994 · 483 citations

Medicine, Oncology, Pathology +17

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.

Sakari Toikkanen, Heikki Helin, Jorma Isola et al. · Journal of Clinical Oncology · 1992 · 317 citations

Medicine, Oncology, Pathology +14